Human and Experimental Hepatocarcinogenesis

REFERENCES

• Schaff Zs, Lapis K, Henson DE. Liver. In: Henson DE, Albores-Saavedra J, editors. Pathology of incipient neoplasia. 2nd ed. Philadelphia: Saunders, 1993. p. 151–66.
   Google Scholar
• Schaff Zs, Lapis K. Liver cancer incidence and its relation to alcoholic liver cirrhosis in Hungary. In: Bannasch P, Keppler D, Weber C, editors. Liver cell carcinoma. Falk Symposium No. 51. Dordrecht: Kluwer, 1989. p. 47–53.
   Google Scholar
• Schaff Zs, Lapis K. Liver cancer and viruses. In: Roberfroid MB, Préat V, editors. Experimental hepatocarcinogenesis. Université Catholique de Louvain, Brussels, Belgium. New York/London: Plenum Press, 1988. p. 63–76.
   Google Scholar
• Schaff Zs, Sárosi I, Hsia CC, Kiss A, Tabor E. P53 in malignant and benign liver lesions. Eur J Cancer 1995;31A:1847–50.
   PubMedGoogle Scholar
• Schaff Zs, Nagy P. Pathology techniques and grading systems in the diagnosis of HCC. In: Okuda K, Tabor E, editors. Liver cancer. New York: Churchill Livingstone, 1997. p. 111–33.
   Google Scholar
• Farber E, Cameron R. The sequential analysis of cancer development. Adv Cancer Res 1980;32:125–6.
   Google Scholar
• Farber E. Review article: chemical carcinogenesis: a biologic perspective. Am J Pathol 1982;106:271–6.
   PubMed Web of Science ®Google Scholar
• Tabor E. Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma. J Med Virol 1994;42:357–65.
   PubMed Web of Science ®Google Scholar
• Schaff Zs, Hsia CC, Sárosi I, Tabor E. Overexpression of TGF-α in benign and malignant liver tumors from European patients. Hum Pathol 1994;25:644–51.
   Google Scholar
• Nagy P, Evarts RP, McMahon JB, Thorgeirsson SS. Role of TGF-beta in normal differentiation and oncogenes in rat liver. Mol Carcinog 1989;2:345–54.
   PubMedGoogle Scholar
• Schaff Zs, Lapis K, Henson DE. Liver. In: Henson DE, Albores-Saavedra J, editors. Pathology of incipient neoplasia. Philadelphia: Saunders, 1986. p. 167–202.
   Google Scholar
• Ivanov X, Mladenov Z, Nedyalkov S, Todorov TG, Yakimov M. Experimental investigations into avian leukosis. V. Transmission, haematology and morphology of avian myelocytomatosis. Bull Inst Pathol Comp Anim Domest 1964;10:5–38.
   Google Scholar
• Chabot JF, Beard D, Langtois AJ, Beard JW. Mesotheliomas of peritoneum, epicardium and pericardium induced by strain MC- 29 avian leukosis virus. Cancer Res 1970;30:1287–308.
   PubMed Web of Science ®Google Scholar
• Beard JW, Hillman AE, Beard D, Lapis K, Heine U. Neoplastic response of the avian liver to host infection with strain MC-29 leukosis virus. Cancer Res 1975;35: 1603–27.
   Google Scholar
• Langlois AJ, Lapis K, Ishizaki R, Beard JW, Bolognesi DP. Isolation of a transplantable cell line induced by the MC-29 avian leukosis virus. Cancer Res 1974;34: 1457–65.
   Google Scholar
• Weber G. Ordered and specific pattern of gene expression in neoplasia. Adv Enzyme Regul 1973;11:79–102.
   PubMedGoogle Scholar
• Weber G. The molecular correlation concept of neoplasia: recent advances and new challenges. In: Morris HP, Griss WE, editors. Morris hepatomas: mechanism of regulation. New York: Plenum Press, 1977. p. 89–116.
   Google Scholar
• Kovalszky I, Jeney A, Asbót R, Lapis K. Biochemistry and enzyme induction in MC-29 virus-induced transplantable avian hepatoma. Cancer Res 1976;36: 2140–5.
   Google Scholar
• Kovalszky I, Jeney A, Bencsáth M, Lapis K. Further studies on the biochemical characterization of the MC-29 virus derived transplantable hepatoma (VTH): binding of 3H cortisol to cytoplastic receptor and dNa. Acta Biol Hung 1984;35: 27–34.
   Google Scholar
• Jeney A, Kovalszky I, Gyapay G, Lapis K, Suba Zs. Chromatin alteration and gene function disorder in MC-29 virus-derived hepatoma. In: Lapis K, Johannessen JV, editors. Liver carcinogenesis. Washington/New York/London: Hemisphere, 1979. p. 339–46.
   Google Scholar
• Prajda N, Eckhardt S, Suba Zs, Lapis K. Biochemical behaviour of MC-29-induced transplantable chicken hepatoma. In: Lapis K, Johannessen JV. Liver carcinogenesis. Washington/New York/London: Hemisphere, 1979. p. 333–41.
   Google Scholar
• Gyapay G, Lapis E, Jeney A, Lapis K. Further studies on the biochemical characterization of the MC-29 virus-derived transplantable hepatoma (VTH). II. Modification of cyclic adesosine-3,5-monophosphate levels by catecholamines, glucagon and Vinca alkaloids in normal chicken liver and VTH. Acta Biol Hung 1984;35: 35–41.
   Google Scholar
• Schaff Zs, Tálas M, Stöger I, Lapis K, Földes I. Neoplastic response of turkey liver to MC-29 leukosis virus. Acta Morphol Acad Sci Hung 1978;26:325–32.
   PubMedGoogle Scholar
• Zalatnai A, Sarosi I, Roth A, Lapis K. Inhibitory and promoting effects of carbon tetrachloride-induced liver cirrhosis on diethylnitrosamine hepatocarcinogenesis in rats. Cancer Lett 1991;57:67–73.
   PubMed Web of Science ®Google Scholar
• Kovalszky I, Szeberényi Sz, Zalatnai A, Vincze I, Lapis K, Jeney A. Modification of DENA-induced hepatocarcinogenesis by CCI4 cirrhosis: comparison of marker enzyme patterns. Carcinogenesis 1992;13:773–8.
   PubMedGoogle Scholar
• Kovalszky I, Kralovanszky J, Jeney A, Lapis K, Karácsonyi S, Széchény A. Alkaline phosphate activity in human and rat liver tumors. Oncology 1991;48:144–8.
   Google Scholar
• Solt DB, Farber E. New principle for the analysis of chemical hepatocarcinogenesis. Nature 1976;263:702–3.
   Web of Science ®Google Scholar
• Evarts RP, Nagy P, Marsden E, Thorgeirsson SS. A precursor–product relationship exists between oval cells and hepatocytes in rat liver. Carcinogenesis 1987;8:1737–40.
   PubMed Web of Science ®Google Scholar
• Nagy P, Evarts RP, Marsden E, Roach J, Thorgeirsson SS. Cellular distribution of c-myc transcrits during chemical hepatocarcinogenesis in rats. Cancer Res 1988;48:5522–7.
   Google Scholar
• Amati B, Land H. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr Opin Genet Dev 1994;4:102–8.
   PubMed Web of Science ®Google Scholar
• Beer DG, Schwarz M, Sawada N, Pitot HC. Expression of H-ras and c-myc protooncogenes in isolated gamma-glutamyl transpeptidase-positive rat hepatocytes and in hepatocellular carcinomas induced by diethylnitrosamine. Cancer Res 1986;46: 2435–41.
   PubMed Web of Science ®Google Scholar
• Cote GJ, Iastra BA, Cook JR, Huang DP, Chiu JF. Oncogene expression in rat hepatomas during hepatocarcinogenesis. Cancer Lett 1985;26:121–7.
   Google Scholar
• Nagy P, Evarts RP, McMahon JB, Snorri S, Thorgeirsson SS.Role of TGF-β in normal differentiation and oncogenesis in rat liver. Mol Carcinog 1989;2:345–54.
   Google Scholar
• Carr BI, Hayashi I, Branum EL, Moses HL. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor. Cancer Res 1986;46:2330–4.
   PubMed Web of Science ®Google Scholar
• McMahon JB, Richards WL, del Campo AA. Differential effects of transforming growth factor-β on proliferation of normal and malignant rat liver epithelial cells in culture. Cancer Res 1986;46:4665–71.
   Google Scholar
• Akhurst J, Fee R, Balmain A. Localized production of TGF-β mRNA in tumor promoter stimulated mouse epidermis. Nature 1988;331:363–5.
   Google Scholar
• Su TS, Lin LH, Liu WY, Chang S, Chou CK, Ting LP, et al. Expression of c-myc gene in human hepatoma. Biochem Biophys Res Comm 1986;132:2264–8.
   Google Scholar
• Santoni-Rugiu E, Nagy P, Jensen RM, Factor MV, Thorgeirsson SS. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-α. Am J Pathol 1996;149:407–28.
   Google Scholar
• Oberhammer F, Nagy P, Tiefenbacher R, Froschl G, Bouzahzah B, Thorgeirsson SS, et al. Anti-androgen cyproterone acetate induces synthesis of transforming growth factor beta-1 in the parenchymal cells of the liver accompanied by an enhanced sensitivity to undergo apoptosis and necrosis without inflammation. Hepatology 1996;23:329–37.
   PubMedGoogle Scholar
• Ohno K, Amman P, Fasciati R, Maier P. Transforming growth factor β1 preferentially induces apoptotic cell death in rat hepatocytes cultured under pericentral equivalent conditions. Toxicol Appl Pharmacol 1996;132:227–36.
   Google Scholar
• Sato S, Matsushima T, Tanaka M. Hepatic tumors in the guppy (Lebistes reticulatus) induced by alfatoxin B₁, dimethylnitrosamine, and 2-acetylaminofluorene. J Natl Cancer Inst 1973; 50:765–78.
   Google Scholar
• Simon K, Lapis K. Carcinogenesis in guppies. J Natl Cancer Inst Monogr 1984;65:71–81.
   Google Scholar
• Lapis K, Simon K. Testing of potential environmental carcinogens in aquarium fish. Med Biol Environ 1983;11:13–6.
   Google Scholar
• Kelly MG, O’Gara RW, Adamson RA, Gadekar K, Botkin CC, Reese WH Jr. Induction of hepatic cell carcinomas in monkeys with V-nitrosodiethylamine. JNatl Cancer Inst 1966;36:323–51.
   PubMedGoogle Scholar
• Thorgeirsson UP, Dalgard DW, Reeves J, Adamson RH. Tumour incidence in a chemical carcinogenesis study of nonhuman primates. Regul Toxicol Pharmacol 1994;19:130–51.
   PubMed Web of Science ®Google Scholar
• Lapis K, Sárosi I, Bocsi J, Thorgeirsson UP. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys. Lab Invest 1995;72:748–59.
   PubMedGoogle Scholar
• Beerman H, Kluin PM, Hermans J, van de Velde CJ, Cornelisse CJ. Prognostic significance of DNA ploidy in a series of 690 primary breast cancer patients. Int J Cancer 1990;45: 34–9.
   Google Scholar
• Nagasue N, Yamanoi A, Takemoto Y, Kimoto T, Uchida M, Chang Y-G, et al. Comparison between diploid and aneuploid hepatocellular carcinomas: a flow cytometric study. Br J Surg 1992;79:667–70.
   Google Scholar
• Ng IOI, Lai ECS, Ho JCW, Chenung LKN, Ng MMT, So MKP. Flow cytometric analysis of DNA ploidy in hepatocellular carcinoma. Am J Clin Pathol 1994;102:80–6.
   PubMedGoogle Scholar
• Lapis K, Bocsi J, Lapis P, Thorgeirsson UP. Flow cytometric DNA ploidy and proliferative activity of diethylnitrosamine- induced hepatocellular carcinoma and pulmonary metastases in monkeys. Hepatology 1995;22:952–61.
   PubMedGoogle Scholar
• Lapis K, Zalatnai A, Tímár F, Thorgeirsson UP. Quantitative evaluation of lysozyme and CD68-positive Kupffer cells in diethylnitrosamine-induced hepatocellular carcinomas in monkeys. Carcinogenesis 1995;16: 3083–5.
   Google Scholar
• Lapis K, Bocsi J, Tímár F, Lapis P, Thorgeirsson UP. Studies of the proliferative activity of diethylnitrosamine-induced hepatocellular carcinomas in monkeys. J Pathol. In press.
   Google Scholar
• Kovalszky I, Schaff Zs, Jeney A. Potential markers (enzymes, proteoglycans) for human liver tumors. Acta Biomed 1993; 64:157–63.
   Google Scholar
• Kovalszky I, Schaff Zs, Lapis K, Jeney A. Marker enzymes of rat hepatocarcinogenesis in human liver tumors. Pathol Oncol Res 1996;2:56–9.
   PubMedGoogle Scholar
• Kojima J, Nakamura N, Kanataki M, Ohmori K. The glycosaminoglycans in human hepatic cancer. Cancer Res 1975;35: 542–7.
   PubMed Web of Science ®Google Scholar
• Kovalszky I, Pogány G, Molnár G, Jeney A, Lapis K, Karâcsonyi S, et al. Altered glycosaminoglycan composition in reactive and neoplastic human liver. Biochem Biophys Res Comm 1990;167:883–90.
   PubMed Web of Science ®Google Scholar
• Kovalszky I, Qudás J, Oláh J, Pogány G, Tótváry J, Tímár J, et al. Inhibition of DNA topoisomerase I activity by heparan sulphate and modulation by basic fibroblast growth factor. Mol Cell Biochem. In press.
   Google Scholar
• Rouslahti E, Yamaguchi Y. Proteoglycans as modulator of growth factor activities. Cell 1991;64:867–9.
   PubMed Web of Science ®Google Scholar
• Schaff Zs, Hsia CC, Sárosi I, Tabor E. Overexpression of TGF-α in benign and malignant liver tumors from European patients. Hum Pathol 1994;25:644–51.
   PubMedGoogle Scholar
• Morimitsu Y, Hsia CC, Kojiro M, Tabor E. Nodules of less- differentiated tumor within or adjacent to hepatocellular carcinoma: relative expression of transforming growth factor-α and its receptor in the different areas of tumor. Hum Pathol 1995;26:1126–32.
   PubMed Web of Science ®Google Scholar
• Lotz G, Kiss A, Schaff Zs. TGF-β1 jô-és rosszindulatú májdaganatokban. Magyar Onkológia 1996;40: 163–8.
   Google Scholar
• Kiss A, Wang NJ, Xie Jp, Thorgeirsson SS. Analysis of TGF-β EGFR, HGF c-met, TGF- βRII and p53 expression in human hepatocellular carcinomas. Clin Cancer Res. In press.
   Google Scholar
• Volpes R, van den Oord J, Desmet VJ. Integrins as differential cell lineage markers of primary liver tumors. Am J Pathol 1993;142:1483–92.
   PubMed Web of Science ®Google Scholar
• Ng IOI, Lai ECS, Fan ST. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer 1994;73:2268–74.
   Google Scholar
• Kopper L, Lapis K, Schaff Zs, Mihalik R, Karácsony S, Szécsény A. Flow cytometric analysis of DNA content in focal nodular hyperplasia and hepatocellular carcinoma. Neoplasma 1991;38:257–63.
   Google Scholar
• Ozturk M, Bressac B, Puisieux PL. P53 mutation in hepatocellular carcinoma after alfatoxin exposure. Lancet 1991;338: 1356–9.
   Google Scholar
• Hsia CC, Kleiner DE, Axiotis CA. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and alfatoxin contamination in the diet. J Natl Cancer Inst 1992;84: 1638–41.
   Google Scholar